Dr. Sandra Aponte, MD, MBA
What this data tells you about Dr. Aponte
Dr. Sandra Aponte is a cytopathology physician in Tampa, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Aponte performed 2,383 Medicare services across 2,278 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aponte received a total of $4,445 from 5 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aponte is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 126014 | Clear | January 31, 2028 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated cervical cancer screening with manual review A cervical or vaginal sample is prepared using an automated thin-layer system. The sample is screened by an automated system and then manually rescreened under physician supervision. |
1,259 | $26 | $117 |
| HPV high-risk type test for cervical cancer screening This test detects high-risk types of human papillomavirus (HPV) DNA or RNA. It is used for cervical cancer screening and must be performed in addition to a Pap test. |
248 | $34 | $81 |
| Automated Pap test with manual rescreening A cervical cancer screening test using an automated system to prepare the sample, followed by a manual review to check for abnormalities. |
200 | $26 | $117 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
198 | $54 | $251 |
| HPV high-risk type nucleic acid test A laboratory test that uses nucleic acid detection to identify high-risk types of human papillomavirus. |
131 | $34 | $141 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
94 | $57 | $77 |
| Gardnerella vaginalis detection test A laboratory test that uses a direct probe technique to detect the presence of Gardnerella vaginalis bacteria. |
62 | $20 | $61 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses a direct probe technique to detect the genetic material of the Trichomonas vaginalis parasite. |
62 | $20 | $61 |
| Candida yeast detection test A laboratory test that uses a direct probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
61 | $20 | $61 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
42 | $74 | $308 |
| Pap test A screening test to check for cervical cancer by collecting cells from the cervix. |
26 | $16 | $113 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aponte is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), with low-engagement industry engagement in the top 14% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aponte experienced with automated cervical cancer screening with manual review?
Does Dr. Aponte receive payments from pharmaceutical companies?
How do Dr. Aponte's costs compare to other cytopathology physicians in Tampa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology